10x Genomics to Report Fourth Quarter and Full Year 2020 Financial Results on February 17, 2021
January 28 2021 - 4:09PM
10x Genomics (Nasdaq: TXG) today announced it will report financial
results for the fourth quarter and full year ended December 31,
2020 after market close on Wednesday, February 17, 2021. The
company’s management will webcast a corresponding conference call
beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to
discuss its results, business developments and outlook.
Live audio of the webcast will be available on the “Investors”
section of the company website at: www.10xgenomics.com. The webcast
will be archived and available for replay for at least 45 days
after the event.
About 10x Genomics10x Genomics is a life
science technology company building products to interrogate,
understand and master biology to advance human health. The
company’s integrated solutions include instruments, consumables and
software for analyzing biological systems at a resolution and scale
that matches the complexity of biology. 10x Genomics products have
been adopted by researchers around the world including 98 of the
top 100 global research institutions and 19 of the top 20 global
pharmaceutical companies, and have been cited in over 2,000
research papers on discoveries ranging from oncology to immunology
and neuroscience. The company’s patent portfolio comprises more
than 1,000 issued patents and patent applications.
Disclosure Information10x Genomics uses filings
with the Securities and Exchange Commission, its website
(www.10xgenomics.com), press releases, public conference calls,
public webcasts and its social media accounts as means of
disclosing material non-public information and for complying with
its disclosure obligations under Regulation FD.
ContactsInvestorsinvestors@10xgenomics.com
Mediamedia@10xgenomics.com
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Jun 2024 to Jul 2024
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Jul 2023 to Jul 2024